Clinical Trials Logo

Mastectomy, Modified Radical clinical trials

View clinical trials related to Mastectomy, Modified Radical.

Filter by:
  • None
  • Page 1

NCT ID: NCT05176938 Not yet recruiting - Pain, Acute Clinical Trials

Effect of Ultrasound Guided Thoracic Interfascial Plane Block Versus Erector Spinae Plane Block After Mastectomy

Start date: January 10, 2022
Phase: N/A
Study type: Interventional

This study will be conducted to compare the efficacy of ultrasound guided thoracic interfascial plane block versus ultrasound guided erector spinae plane block on acute and chronic pain after modified radical mastectomy surgery.

NCT ID: NCT03456661 Terminated - Breast Cancer Clinical Trials

Comparison Between Levobupivacaine and Levobupivacaine With Dexmedetomidine in Ultrasound Guided Pectoral Nerve Block

Start date: May 19, 2014
Phase: Phase 4
Study type: Interventional

A double blind prospective randomized controlled trial in which the effect of single shot levobupivacaine 0,25% will be compared with the effect of levobupivacaine 0.25% in association with dexmedetomidine when performing an ultrasound guided modified pectoral nerve block , in patients undergoing a mastectomy with axillar procedure. The difference in effect will be evaluated by monitoring the postoperative morphine consumption in both groups . The hypothesis is that there is a significant decrease in morphine consumption during the first 24h postoperatively due to association of dexmedetomidine to the local anesthetic compared to the local anesthetic alone when performing a ultrasound guided modified pectoral nerve block. The morphine consumption will be the primary outcome parameter.

NCT ID: NCT02551133 Active, not recruiting - Clinical trials for Mastectomy, Modified Radical

Comparison of Dexamethasone Doses on Persistent Postmastectomy Pain

Start date: November 2014
Phase: Phase 4
Study type: Interventional

This study evaluates the effect of dexamethasone on persistent surgical pain after mastectomy operations. Half of the participants will receive 0.1 mg/kg dexamethasone and the other half will receive 0.2 mg/kg dexamethasone.